Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Exercise of options

31 Jan 2008 17:03

Wilmington Group Plc31 January 2008 Wilmington Group Plc31 January 2008 Wilmington Group plc ("Wilmington" or the "Company") announces that options heldby Colin Bailey-Wood, a former senior manager of businesses disposed of by theCompany on 14 August 2007, over 100,000 ordinary shares of 5p each in theCompany have today been exercised. These options were all exercisable at 146.5pand were private options granted by certain individuals who were all directorsof the Company at the time of grant, namely Rory Conwell, Ahmed Zahedieh andBrian Gilbert, over shares in the Company held by them. The grant was announcedto the market on 28 February 2002. Rory Conwell continues to be an executivedirector of the Company and Ahmed Zahedieh is company secretary. Colin Bailey-Wood was a senior manager of the businesses that the Companydisposed of on 14 August 2007, and the terms on which the options were grantedprovide that Colin has 6 months from the date of such sale to exercise suchoptions, which is up until 14 February 2008. Colin is no longer employed by theCompany or any of its subsidiaries and as such is not subject to the provisionsof the Model Code under the Listing Rules of the UKLA ("Model Code"). The Company is currently in a close period until the release of its interimnumbers at the end of February 2008. The exercise of the options by ColinBailey-Wood means that Rory Conwell and Ahmed Zahedieh are obliged to sellshares in the Company to him. The sale by them of these shares would technicallybe caught by the Model Code as they are both "restricted persons" within themeaning of the Model Code and the Company is in a close period. However, as theexercise of the options is outside of their control and, if Colin was notallowed to exercise such options he would be time barred from doing so and hencewould lose the benefit of such options, the Company has deemed it appropriate inthese circumstances to permit Rory Conwell and Ahmed Zahedieh to sell shares inthe Company held by them to Colin Bailey-Wood pursuant to the exercise of suchoptions. As a result of this, the details of the shares held and the remaining optionsgranted over such shares, by Rory Conwell and Ahmed Zahedieh are as follows: Rory Conwell Ahmed ZahediehTotal number of shares in issue inwhich director/co secretary is interested(including shares subject to option) 3,909,356 1,916,805 Share number as a percentage of ordinaryissued share capital 4.64% 2.27% Number of ordinary shares over whichoptions granted 28,571 14,286 Such number as a percentage of theOrdinary issued share capital 0.03% 0.02% Enquiries: Ahmed ZahediehCompany Secretary 0207 422 6800 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Apr 202611:20 amRNSHolding(s) in Company
15th Apr 20263:56 pmRNSBoard changes
15th Apr 202611:21 amRNSSave As You Earn Options
11th Mar 202611:00 amRNSDirector Declaration
11th Mar 202611:00 amRNSDirector Declaration
26th Feb 20267:00 amRNSHalf-year Financial Report
11th Feb 20262:44 pmRNSNotice of half year-end results
21st Jan 202611:19 amRNSNotice of Half Year Results
23rd Dec 20257:00 amRNSAppointment of Joint Corporate Broker
23rd Dec 20257:00 amRNSAppointment of Joint Corporate Broker
5th Dec 20259:56 amRNSAcquisition of Conversia completed
28th Nov 20254:23 pmRNSDirector/PDMR Shareholding
28th Nov 202511:22 amRNSAcquisition of Conversia cleared to complete
25th Nov 20259:19 amRNSResult of AGM
10th Nov 20255:54 pmRNSDirectorate change
1st Oct 20252:51 pmRNSDirector/PDMR Shareholding
1st Oct 20252:49 pmRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSTotal Voting Rights
22nd Sep 202512:48 pmRNSDirector/PDMR Shareholding- Replacement
22nd Sep 202511:52 amRNSDirector/PDMR Shareholding
22nd Sep 20257:00 amRNSFinancial results for the year ended 30 June 2025
5th Sep 202510:58 amRNSHolding(s) in Company
1st Sep 20257:00 amRNSNotice of year-end results
29th Aug 202511:07 amRNSHolding(s) in Company
12th Aug 20257:03 amRNSProposed acquisition of Conversia
12th Aug 20257:00 amRNSDirector Declaration
1st Aug 20257:00 amRNSAppointment of Joint Corporate Broker
30th Jul 20257:00 amRNSStatement in relation to a potential acquisition
23rd Jul 20257:00 amRNSTrading Statement
1st Jul 20257:00 amRNSTotal Voting Rights
26th Jun 20259:00 amRNSDirector/PDMR Shareholding
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20259:30 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.